Evaluation of an immunochromatographic assay kit for rapid identification of Mycobacterium tuberculosis complex in clinical isolates. by �젙�꽍�썕
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2009, p. 481–484 Vol. 47, No. 2
0095-1137/09/$08.000 doi:10.1128/JCM.01253-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Evaluation of an Immunochromatographic Assay Kit for Rapid
Identification of Mycobacterium tuberculosis Complex in
Clinical Isolates
Mi Young Park,1* Young Jin Kim,1 Sang Hyun Hwang,1 Hyoung Hoi Kim,1 Eun Yup Lee,1
Seok Hoon Jeong,2 and Chulhun L. Chang1,3
Department of Laboratory Medicine, School of Medicine,1 and Medical Research Institute,3 Pusan National University, Busan, and
Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul,2 Korea
Received 2 July 2008/Returned for modification 16 August 2008/Accepted 22 November 2008
We evaluated a new immunochromatographic assay (ICA) using mouse monoclonal anti-MPT64 antibody
for rapid discrimination between Mycobacterium tuberculosis and nontuberculous mycobacteria in clinical
isolates. A study with mycobacteria and other organisms showed excellent sensitivity (99%) and specificity
(100%) and an appropriate detection limit (105 CFU/ml) when tested withM. tuberculosis H37Rv. This ICA can
simplify the identification of M. tuberculosis in clinical laboratories.
Tuberculosis is a global problem and the single most com-
mon cause of death from any bacterial agent (15, 22). Myco-
bacterium tuberculosis and nontuberculous mycobacteria
(NTM) are different clinically, so prompt detection, isolation,
and discrimination are essential for appropriate management
(3, 7).
The MPT64 protein is highly specific for M. tuberculosis
complex, including M. tuberculosis, Mycobacterium africanum,
Mycobacterium bovis, and some, although not all, substrains of
M. bovis BCG (1, 6, 16, 18, 23), and can be detected in culture
isolates and biopsy samples (1, 7, 17, 18, 20). Recently, Stan-
dard Diagnostics (SD, Yongin, Korea) developed a simple and
rapid assay using a mouse monoclonal anti-MPT64 antibody to
discriminate between M. tuberculosis complex and NTM by
immunochromatography. Mouse monoclonal anti-MPT64 an-
tibodies (SD Bioline TB Ag MPT64; SD) are immobilized on
a nitrocellulose membrane as the capture material. Another
antibody, which recognizes another epitope of MPT64 and has
been conjugated with colloidal gold particles, is used for anti-
gen capture and detection in a sandwich-type assay.
We evaluated the clinical usefulness of the kit using myco-
bacteria and other organisms. To determine specificity, 137
bacterial isolates (68 species), 20 fungal isolates (10 species),
53 reference mycobacterial isolates (40 species), and 51 NTM
isolates from clinical samples were tested (Tables 1 to 3). To
determine sensitivity, 159 M. tuberculosis complex strains
grown on 3% Ogawa medium (isolated at Pusan National
University Hospital), 60 strains from Bactec MGIT 960 culture
tubes (isolated at Kosin University Gospel Hospital), and one
reference strain, M. tuberculosis H37Rv, were tested. All bac-
terial, fungal, and mycobacterial isolates were stock cultures
that had been kept in a 4°C refrigerator or a 72°C deep
freezer for as long as 18 months. The cultured mycobacteria
were identified by acid-fast bacillus stain, nucleic acid amplifi-
cation, and DNA microarray (10, 14). Finally, to determine the
detection limit, a series of diluted suspensions of M. tubercu-
losis H37Rv were inoculated onto Middlebrook 7H10 agar and
the resulting colonies were counted (19). One hundred micro-
liters of sample taken from liquid medium was applied directly
to the sample well without preparation. Three or four colonies
were scraped from the solid medium and suspended in 300 l
of extraction buffer (SD); then, 100 l of the suspension was
added to the sample well. If there was condensation fluid in
egg-based medium, 100 l of the fluid was applied directly to
the sample well, instead of using extraction buffer. Tests were
interpreted 15 min after sample application. The presence of a
control band alone indicates a negative result, whereas the
presence of two color bands (control and test bands), no mat-
ter which band appears first, indicates a positive result. A color
band of any intensity was read as a positive reaction (Fig. 1). If
the control band was not visible after 15 min, the result was
considered invalid, and the sample was retested.
All bacterial, fungal, and NTM isolates, including reference
strains, were negative by the immunochromatographic assay
(ICA) (specificity, 100%). One hundred fifty-eight of 159 M.
tuberculosis complex strains grown on solid medium and 59 of
60 strains from liquid medium were positive by the ICA (over-
all sensitivity, 98.6%). The 1:128-diluted suspension (5.5  105
CFU/ml) revealed 10% reaction intensity, and the band inten-
sity gradually weakened with serial dilutions until the 1:1,024
suspension (6.8  104 CFU/ml) was negative. The detection
limit thus was determined to approximate 105 CFU/ml.
Although most culture-positive mycobacteria are M. tuber-
culosis in regions where tuberculosis is highly prevalent, NTM
isolates have been increasing gradually, such that now 20 to
30% of mycobacteria found in clinical specimens in Korea are
NTM (13). These organisms trigger diseases and true infec-
tions and thus can be important clinically (21). Because of the
complexity of test methods, many small hospital laboratories
do not discriminate between M. tuberculosis and NTM (4, 11,
12), meaning that NTM are inappropriately managed with
first-line antituberculosis drugs (12, 24), worsening the pa-
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tient’s condition and raising the risk of drug resistance. Thus,
exact and rapid identification of mycobacteria is important,
and a simple, sensitive, and specific identification method is
necessary. Direct staining of a colony is simple and fast but
does not discriminate between M. tuberculosis and NTM, and
traditional biochemical tests not only can produce equivocal
results but also take a long time (2). Chemiluminescent DNA
probes, nucleic acid amplification, high-performance liquid
chromatography, and sequencing of 16S rRNA genes are more
TABLE 1. List of bacterial and fungal strains
Species (no. of strains)
Bacteria
Acinetobacter baumannii (4)
Aeromonas caviae (2)
Aeromonas hydrophila (3)
Aeromonas veronii (2)
Aeromonas veronii biovar sobria (1)
Alcaligenes faecalis (2)
Alcaligenes xylosoxidans (2)
Bacillus cereus (2)
Bordetella bronchiseptica (2)
Branhamella catarrhalis (2)
Brevundimonas vesicularis (2)
Chryseobacterium indologenes (2)
Chryseobacterium meningosepticum (2)
Citrobacter freundii (4)
Comamonas acidovorans (2)
Escherichia coli (2)
Enterobacter aerogenes (2)
Enterobacter agglomerans (2)
Enterobacter cloacae (2)
Enterobacter intermedius (2)
Enterococcus avium (2)
Enterococcus casseliflavus (2)
Enterococcus faecalis (2)
Enterococcus faecium (2)
Enterococcus gallinarum (2)
Enterococcus raffinosis (2)
Flavimonas oryzihabitans (2)
Flavobacterium indologenes (2)
Klebsiella ornithinolytica (2)
Klebsiella oxytoca (2)
Klebsiella ozaenae (2)
Klebsiella pneumoniae (2)
Kocuria rosea (1)
Kocuria varians (2)
Leclercia adecarboxylata (2)
Morganella morganii (2)
Myroides spp. (2)
Neisseria gonorrhoeae (2)
Ochrobactrum anthropi (2)
Pichia anomala (2)
Pichia ohmeri (2)
Plesiomonas shigelloides (2)
Proteus vulgaris (2)
Providencia rettgeri (3)
Providencia stuartii (2)
Pseudomonas aeruginosa (2)
Pseudomonas fluorescens (2)
Ralstonia pickettii (2)
Salmonella group D (1)
Salmonella paratyphi A (2)
Serratia marcescens (2)
Shigella sonnei (2)
Sphingobacterium spiritivorum (2)
Sphingomonas paucimobilis (2)
Staphylococcus aureus (4)
Staphylococcus epidermidis (2)
Staphylococcus haemolyticus (2)
Staphylococcus saprophyticus (2)
Staphylococcus, coagulase negative (2)
Stenotrophomonas maltophilia (2)
Streptococcus agalactiae (2)
Streptococcus dysgalactiae (2)
Streptococcus mitis (2)
Streptococcus pneumoniae (2)
Streptococcus pyogenes (2)
Streptococcus viridans group (2)
Subtotal (137)
Fungi
Candida albicans (3)
Candida dubliniensis (2)
Candida glabrata (2)
Candida krusei (1)
Candida pelliculosa (2)
Candida tropicalis (2)
Cryptococcus humicolus (2)
Cryptococcus neoformans (2)
Trichosporon asahii (2)
Trichosporon beigelii (2)
Subtotal (20)
Total (157)
TABLE 2. List of reference mycobacterial strains
Mycobacterium species and strain
M. abscessus
ATCC 19977
ATCC 23003
M. acapulcensis KTCC9501
M. agri KTCC9502
M. asiaticum KTCC9503
M. austroafricanum KTCC9504
M. avium ATCC 25291
M. branderi ATCC 51788
M. celatum ATCC 51131
M. chelonae KTCC9505
M. diernhoferi KTCC9506
M. flavescens
ATCC 14474
ATCC 23008
M. fortuitum
KTCC1122
KTCC9510
M. gastri ATCC 15754
M. gilvum KTCC9512
M. gordonae
KTCC3036
KTCC9513
M. interjectum ATCC 51457
M. intermedium ATCC 51846
M. intracellulare
KIT41105
KTCC9514
M. kansasii KTCC9515
M. marinum
ATCC 11564
ATCC 927
M. malmoense ATCC 29571
M. morikaense KTCC9516
M. mucogenicum
KTCC19088
ATCC 49650
M. neoaurum ATCC 25795
M. nonchromogenicum ATCC 19530
M. peregrinum
KTCC9615
ATCC 14467
M. phlei KTCC2192
M. porcinum KTCC9517
M. pulveris KTCC9518
M. scrofulaceum
KTCC9519
ATCC 19981
M. senegalense ATCC 35796
M. shimoidei ATCC 27962
M. simiae
ATCC 15080
ATCC 25275
M. smegmatis KTCC1057
M. sphagni ATCC 33027
M. szulgai KTCC9520
M. terrae
KTCC9614
ATCC 15755
M. triviale
ATCC 23290
ATCC 23292
M. tuberculosis H37Rv
M. vaccae
KTCC19087
ATCC 15483
M. xenopi ATCC 19250
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sophisticated methods that require expensive equipment (2, 5,
10, 14). Although our study was conducted with culture spec-
imens and needs further direct testing with clinical specimens,
the ICA was shown to be rapid and easy and to have high
sensitivity and specificity.
In this study, one isolate of M. tuberculosis complex from
solid medium was negative. This organism was subcultured
twice on 3% Ogawa medium with failure of growth, suggesting
that the culture was kept too long in a slant culture format in
a refrigerator before testing and lost its viability. The negative
isolate that was grown in liquid medium was subcultured on
3% Ogawa medium, and a repeat test also was negative. Ac-
cording to a recent study, MPT64, once secreted into the me-
dium, is stable, as the test remains positive even if performed
1 year after the detection of growth in either solid or liquid
medium (7). This suggests another reason for the negative test
results besides storage. Some M. bovis BCG substrains lack
MPT64 production (1, 6, 16, 18), and this could have been a
nonproducing strain. Another possible explanation for the neg-
ative test results is that the strain had mutations within the
mpt64 gene, leading to the production of an incomplete pro-
tein. By sequencing, Hirano et al. identified several such mu-
tations, including deletion of nucleotides, point mutations, and
an IS6110 insertion mutation at nucleotide position 501 (8, 9).
The ICA is rapid and easy, is applicable for specimens from
both liquid and solid media, and does not require any special
equipment. It showed excellent sensitivity (99%) and speci-
ficity (100%) and an appropriate detection limit (105 CFU/ml).
It can simplify the identification of M. tuberculosis complex
strains, avoiding the technical complexity of PCR and similar
identification techniques in clinical laboratories.
C. L. Chang participated in the development of the MPT64 ICA kit
as a scientific consultant.
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